Patents Assigned to Castle Biosciences Incorporated
  • Compositions for and methods of detecting, diagnosing, and prognosing thymic cancer
    Patent number: 10233502
    Abstract: Biomarkers are provided for detecting, diagnosing and prognosing thymic cancer in individuals having or suspected of having thymic cancer. In addition, kits are provided for measuring expression levels or the presence of the biomarkers associated with thymic cancer for detecting, diagnosing and prognosing thymic cancer. Furthermore, methods are provided for detecting, diagnosing and prognosing thymic cancer in individuals having or suspected of having thymic cancer via the biomarkers.
    Type: Grant
    Filed: June 22, 2012
    Date of Patent: March 19, 2019
    Assignees: Indiana University Research and Technology Corporation, Castle Biosciences, Incorporated
    Inventors: Sunil Badve, Yesim Gokmen-Polar, Patrick J. Loehrer, Robert Cook, Derek Maetzold
  • Compositions for and Methods of Detecting, Diagnosing, and Prognosing Thymic Cancer
    Publication number: 20140371081
    Abstract: Biomarkers are provided for detecting, diagnosing and prognosing thymic cancer in individuals having or suspected of having thymic cancer. In addition, kits are provided for measuring expression levels or the presence of the biomarkers associated with thymic cancer for detecting, diagnosing and prognosing thymic cancer. Furthermore, methods are provided for detecting, diagnosing and prognosing thymic cancer in individuals having or suspected of having thymic cancer via the biomarkers.
    Type: Application
    Filed: June 22, 2013
    Publication date: December 18, 2014
    Applicants: Indiana University Research and Technology Corporation, Castle Biosciences Incorporated
    Inventors: Sunil Badve, Yesim Gokmen-Polar, Patrick J. Loehrer, Robert Cook, Derek Maetzold